Physician profile
Sonya Wali
NPI 1144832932
$5,626.93
in general payments reported to CMS, 2019-2025
18 companies · $3,695 in 2025
The $3,695 reported for 2025 was more than what 91% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $1,932 · 2025: $3,695.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,961 · Food and Beverage: $2,666.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,961.26 |
| Food and Beverage | $2,665.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $1,661.30 | 2025 | |
| Stryker Corporation | $1,069.07 | 2024-2025 | 7 X 23mm Citrelock Implant, Viaflow, Easyfuse |
| Treace Medical Concepts, INC. | $721.86 | 2025 | |
| Fortis Surgical, LLC | $517.21 | 2024-2025 | |
| Organogenesis INC. | $385.08 | 2024-2025 | Puraply Wound Matrix, Puraply Franchise, Simplimax |
| Kerecis Limited | $283.58 | 2024-2025 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Surgiclose |
| Bioventus LLC | $204.51 | 2024-2025 | Exogen Ultrasound Bone Healing System |
| Globus Medical, INC. | $195.10 | 2025 | Senza |
| Paragon 28, INC. | $132.54 | 2025 | Precision Mis Bunion |
| Smith+Nephew, INC. | $97.79 | 2024-2025 | Stravix, Grafix, Oasis |
| Biocomposites INC | $94.57 | 2025 | Stimulan |
| Averitas Pharma INC. | $79.79 | 2024-2025 | Qutenza |
| Convatec INC. | $55.55 | 2024 | |
| Depuy Synthes Sales INC. | $39.96 | 2025 | Motoband, Fibergraft Bg Morsels |
| Osteoremedies, LLC | $29.73 | 2025 | Blastx |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Reprise Biomedical, INC. | $25.50 | 2025 | Miro3d |
| Ibsa Pharma INC. | $17.76 | 2025 | Tirosint, Flector, Licart |
| Mimedx Group, INC. | $16.03 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sonya Wali listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.